Madrigal Pharmaceuticals, Inc. (MDGL)
534.49
+1.37
(+0.26%)
USD |
NASDAQ |
Sep 11, 16:00
534.04
-0.45
(-0.08%)
After-Hours: 20:00
Madrigal Pharmaceuticals Price : 534.49 for Sept. 11, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 11, 2026 | 536.02 | 546.56 | 531.36 | 534.49 | 187643.0 |
| Sep 10, 2026 | 543.12 | 543.12 | 519.10 | 533.12 | 225767.0 |
| Sep 09, 2026 | 529.50 | 549.97 | 526.88 | 546.66 | 281255.0 |
| Sep 08, 2026 | 534.17 | 540.00 | 526.67 | 534.16 | 199463.0 |
| Sep 04, 2026 | 536.82 | 547.92 | 535.60 | 541.08 | 177171.0 |
| Sep 03, 2026 | 548.83 | 552.08 | 540.44 | 542.61 | 143455.0 |
| Sep 02, 2026 | 543.54 | 551.45 | 537.10 | 546.93 | 202818.0 |
| Sep 01, 2026 | 540.03 | 548.60 | 532.66 | 538.71 | 165755.0 |
| Aug 31, 2026 | 530.60 | 542.05 | 523.29 | 540.03 | 134578.0 |
| Aug 28, 2026 | 539.38 | 542.16 | 528.28 | 533.76 | 268664.0 |
| Aug 27, 2026 | 538.46 | 545.82 | 532.30 | 543.69 | 221854.0 |
| Aug 26, 2026 | 510.14 | 550.33 | 507.48 | 538.88 | 345540.0 |
| Aug 25, 2026 | 515.95 | 523.35 | 506.29 | 512.16 | 189200.0 |
| Aug 24, 2026 | 515.89 | 517.00 | 507.18 | 511.97 | 145524.0 |
| Aug 21, 2026 | 520.09 | 530.67 | 514.90 | 516.74 | 179832.0 |
| Aug 20, 2026 | 537.01 | 539.73 | 518.65 | 519.09 | 264483.0 |
| Aug 19, 2026 | 528.99 | 542.78 | 527.46 | 540.16 | 221135.0 |
| Aug 18, 2026 | 524.50 | 533.68 | 514.57 | 524.37 | 356198.0 |
| Aug 17, 2026 | 509.16 | 527.22 | 506.84 | 524.87 | 307441.0 |
| Aug 14, 2026 | 504.34 | 509.89 | 494.90 | 507.56 | 234655.0 |
| Aug 13, 2026 | 539.73 | 540.00 | 506.02 | 507.37 | 277891.0 |
| Aug 12, 2026 | 536.00 | 544.49 | 527.59 | 536.20 | 285551.0 |
| Aug 11, 2026 | 516.97 | 535.57 | 512.79 | 535.27 | 415197.0 |
| Aug 10, 2026 | 502.92 | 517.48 | 501.21 | 515.34 | 283739.0 |
| Aug 07, 2026 | 511.97 | 517.32 | 502.78 | 510.04 | 347529.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Alnylam Pharmaceuticals, Inc. | 248.68 |
| Exelixis, Inc. | 56.12 |
| United Therapeutics Corp. | 497.11 |
| Karyopharm Therapeutics, Inc. | 1.61 |
| ACADIA Pharmaceuticals, Inc. | 27.83 |
Price Related Metrics
| PS Ratio | 10.77 |
| PEG Ratio | -145.62 |
| Price to Book Value | 23.57 |
| Earnings Yield | -2.41% |
| Market Cap | 12.34B |
| PEGY Ratio | -145.62 |